Michael R. Bristow
2020
In 2020, Michael R. Bristow earned a total compensation of $1.1M as President and Chief Executive Officer at ARCA biopharma, a 258% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,000 |
|---|---|
| Option Awards | $619,976 |
| Salary | $286,083 |
| Other | $11,528 |
| Total | $1,061,587 |
Bristow received $620K in option awards, accounting for 58% of the total pay in 2020.
Bristow also received $144K in non-equity incentive plan, $286.1K in salary and $11.5K in other compensation.
Rankings
In 2020, Michael R. Bristow's compensation ranked 8,380th out of 13,090 executives tracked by ExecPay. In other words, Bristow earned more than 36.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,380 out of 13,090 | 36th |
Division Manufacturing | 3,560 out of 5,617 | 37th |
Major group Chemicals And Allied Products | 1,442 out of 2,248 | 36th |
Industry group Drugs | 1,254 out of 1,948 | 36th |
Industry In Vitro and In Vivo Diagnostic Substances | 27 out of 60 | 55th |
Source: SEC filing on April 21, 2021.
Bristow's colleagues
We found two more compensation records of executives who worked with Michael R. Bristow at ARCA biopharma in 2020.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019